XML 105 R32.htm IDEA: XBRL DOCUMENT v3.25.1
Stock-based Compensation Plans (Tables)
12 Months Ended
Dec. 31, 2024
Share-Based Payment Arrangement [Abstract]  
Schedule of Stock Option Activity
The following table summarizes stock option activity for the year ended December 31, 2024 and 2023 under the 2019 Plan:
OptionsWeighted-
Average
Exercise
Price
Weighted-
Average
Remaining
Contractual
Term (Years)
Aggregate
Intrinsic
Value
Outstanding as of January 1, 20246,196,140 $7.15 
Granted10,345,598 $1.24 
Exercised— $— 
Repricing modification— $9.55 
Forfeited or expired(405,693)$2.05 
Outstanding as of December 31, 202416,136,045 $1.52 8.61$— 
Options vested and expected to vest as of December 31, 202416,136,045 $1.52 8.61$— 
Options exercisable as of December 31, 20244,657,611 $2.03 7.00$— 
OptionsWeighted-
Average
Exercise
Price
Weighted-
Average
Remaining
Contractual
Term (Years)
Aggregate
Intrinsic
Value
Outstanding as of January 1, 20233,791,688 $11.33 
Granted2,810,564 $1.70 
Exercised— $— 
Forfeited or expired(406,112)$8.52 
Outstanding as of December 31, 20236,196,140 $7.15 8.14$185,169 
Options vested and expected to vest as of December 31, 20236,196,140 $7.15 8.14$185,169 
Options exercisable as of December 31, 20232,534,017 $11.33 7.19$12,381 
Schedule of Valuation Assumptions Used The following are the underlying assumptions used in the Black-Scholes-Merton option pricing model to determine the fair value of stock options granted to employees and to non-employees under this stock plan:
20242023
Risk-free interest rate4.11%3.98%
Expected dividend yield0%0%
Expected volatility101.0%96.1%
Expected term of options (years)6.06.0
Schedule of Stock-based Compensation Expense for Stock Awards Recognized
Total stock-based compensation expense for all stock awards recognized in the accompanying audited consolidated statements of operations is as follows (in thousands):
 Year
 Ended December 31,
 20242023
Research and development$3,635 $3,398 
General and administrative4,892 3,704 
Total$8,527 $7,102